NU Skin Enterprises (NUS) Stock Price

Currency:

NU Skin Enterprises Price

🇺🇸NYSE·CLOSED

7.33USD

Market closed

Today +/-

-0.03 USD

Today %

-0.41 %

NU Skin Enterprises (NUS) — ISIN US67018T1051. The NU Skin Enterprises stock price was 7.33 USD in 2026. Revenue was 1.44 B USD. Earnings were 69.92 M USD. P/E ratio was 5.2. NU Skin Enterprises operates in the Non-cyclical consumption sector.

NU Skin Enterprises stock price

Ex-Dividend

Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of NU Skin Enterprises over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how NU Skin Enterprises stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing NU Skin Enterprises's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

NU Skin Enterprises Stock Price History

Date	NU Skin Enterprises Price
3/11/2026	7.33 USD
3/10/2026	7.36 USD
3/9/2026	7.28 USD
3/6/2026	7.65 USD
3/5/2026	7.62 USD
2/26/2026	8.65 USD
2/25/2026	8.57 USD
2/24/2026	8.51 USD
2/23/2026	8.60 USD
2/20/2026	8.73 USD
2/19/2026	8.68 USD
2/18/2026	8.50 USD
2/16/2026	8.61 USD
2/12/2026	8.36 USD
2/11/2026	10.21 USD
2/10/2026	10.17 USD

API Docs Get API Key

NU Skin Enterprises Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

Revenue

EBIT

Net Income

Details

API Docs Get API Key

NU Skin Enterprises Income Statement, Balance Sheet, Cash Flow Statement

Last updated Mar 12, 2026, 10:01 AM

REVENUE (B USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (B USD)

NET INCOME (M USD)

NET INCOME GROWTH (%)

DIVIDEND (USD)DIV. (USD)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

DOCUMENTS

1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e
0	0	0.04	0.11	0.25	0.36	0.76	0.95	0.91	0.89	0.88	0.89	0.96	0.99	1.14	1.18	1.12	1.16	1.25	1.33	1.54	1.72	2.13	3.18	2.57	2.25	2.21	2.28	2.68	2.42	2.58	2.7	2.23	1.97	1.73	1.51	1.44	1.54
–	–	–	161.90	130.91	40.94	112.57	25.23	-4.20	-2.08	-1.68	0.68	8.93	2.28	15.31	3.78	-5.51	3.77	7.78	6.74	15.48	11.84	24.03	48.97	-19.11	-12.53	-1.78	3.26	17.55	-9.67	6.65	4.42	-17.44	-11.51	-12.04	-12.70	-4.63	7.07
–	–	66.67	64.55	65.75	73.18	77.53	79.96	77.00	83.00	83.05	79.89	80.19	82.05	83.20	82.54	82.51	81.94	81.72	81.67	82.24	81.27	83.44	84.07	81.39	78.19	77.34	77.97	76.30	75.99	74.51	74.95	71.64	68.92	68.19	78.11	81.90	76.49
1.18	1.18	0.03	0.07	0.17	0.26	0.59	0.76	0.7	0.74	0.73	0.71	0.77	0.81	0.95	0.97	0.92	0.95	1.02	1.09	1.26	1.4	1.78	2.67	2.09	1.76	1.71	1.78	2.04	1.84	1.92	2.02	1.59	1.36	1.18	1.18	1.18	1.18
-1	-1	2	4	17	40	84	118	103	86	61	50	64	67	77	74	32	43	65	89	136	153	221	364	189	133	143	129	121	173	191	147	104	8	-146	64	69	0
–	–	-300.00	100.00	325.00	135.29	110.00	40.48	-12.71	-16.50	-29.07	-18.03	28.00	4.69	14.93	-3.90	-56.76	34.38	51.16	36.92	52.81	12.50	44.44	64.71	-48.08	-29.63	7.52	-9.79	-6.20	42.98	10.40	-23.04	-29.25	-92.31	-1,925.00	-143.84	7.81	–
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.36	0.40	0.42	0.44	0.46	0.50	0.59	0.80	1.20	1.38	1.40	1.42	1.44	1.46	1.48	1.50	1.52	1.54	1.56	0.24	0.24	0.06	-
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	11.11	5.00	4.76	4.55	8.70	18.00	35.59	50.00	15.00	1.45	1.43	1.41	1.39	1.37	1.35	1.33	1.32	1.30	-84.62	–	-75.00	–
84.4	84.4	84.4	84.4	84.4	80.5	83	85.3	87	87.9	85.6	83.9	83.1	79.5	72.6	71.4	70.5	65.6	64.1	64.3	64.5	64.5	63	61.4	60.9	59.1	56.1	54.9	56.5	55.9	52.8	51.4	50.5	49.86	49.66	49.66	49.66	49.66
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales NU Skin Enterprises generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue NU Skin Enterprises retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare NU Skin Enterprises's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares NU Skin Enterprises has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against NU Skin Enterprises's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

ASSETS

CASH BALANCE (M USD)

RECEIVABLES (M USD)

OTHER RECEIVABLES (M USD)OTHER REC. (M USD)

INVENTORIES (M USD)

OTHER CURRENT ASSETS (M USD)OTHER CURRENT LIAB. (M USD)

CURRENT ASSETS (B USD)

TANGIBLE ASSETS (M USD)

LONG-TERM INVESTMENTS (M USD)LONG-T. INVEST. (M USD)

LONG-TERM RECEIVABLES (M USD)LONG-T. REC. (M USD)

INTANGIBLE ASSETS (M USD)INTANGIBLE ASSETS (M USD)

GOODWILL (M USD)

OTHER NON-CURRENT ASSETS (M USD)OTHER NON-CURRENT ASSETS (M USD)

NON-CURRENT ASSETS (B USD)

TOTAL ASSETS (B USD)

LIABILITIES

COMMON STOCK (M USD)

ADDITIONAL PAID-IN CAPITAL (M USD)

RETAINED EARNINGS (B USD)

OTHER EQUITY (k USD)OTHER EQUITY (k USD)

UNREALIZED GAINS/LOSSES (M USD)UNREAL. GAINS/LOSSES (M USD)

EQUITY (B USD)

LIABILITIES (M USD)

PROVISIONS (M USD)

OTHER SHORT-TERM LIABILITIES (M USD)OTHER SHORT-TERM LIAB. (M USD)

SHORT-TERM DEBTS (M USD)SHORT-TERM DEBTS (M USD)

SHORT-TERM PORTION OF LONG-TERM DEBTS (M USD)LONG-TERM DEBT PORTION (M USD)

SHORT-TERM RECEIVABLES (M USD)SHORT-TERM REC. (M USD)

LONG-TERM LIABILITIES (M USD)LONG-T. LIAB. (M USD)

DEFERRED TAXES (k USD)

OTHER LIABILITIES (M USD)OTHER LIAB. (M USD)

LONG-TERM LIABILITIES (M USD)LONG-T. LIABILITIES (M USD)

DEBT (B USD)

TOTAL CAPITAL (B USD)

1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

16.3	63.2	207.1	174.3	188.8	110.2	64	75.9	120.3	122.6	120.1	155.4	121.4	92.6	114.6	158	235.7	294.9	340	548.2	301.5	305.2	369.2	439.4	399.7	345.3	457.2	356	279.7	270.11	201.95
18.9	5	16.9	34.1	36	34.6	31.4	32.3	19.5	15.1	16.1	16.7	19.4	23.4	16.5	22.5	25.7	31.6	36.9	68.7	35.8	35.5	31.2	33.2	53.3	50.4	63.4	41.3	47.4	72.88	50.78
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.8	0	0	0	0	2.8	9.3	0	0
15.6	32.7	44.9	69.5	79.5	85.8	82	84.3	88.3	83.3	87.5	99.4	92.1	100.8	114.4	105.7	114.5	112.1	135.9	339.7	338.5	265.3	249.9	253.5	295.8	275.9	314.4	399.9	346.2	279.98	190.24
3.5	3.4	11.3	38.7	50.5	52.4	44.5	45.4	48.3	60.2	44.7	36.7	44.1	49.6	44.9	51.7	46.7	91.5	75.9	161.8	158.9	100.4	57.2	51.8	50.4	68.7	68.2	73	77.3	78.9	95.62
0.05	0.1	0.28	0.32	0.35	0.28	0.22	0.24	0.28	0.28	0.27	0.31	0.28	0.27	0.29	0.34	0.42	0.53	0.59	1.12	0.83	0.71	0.71	0.78	0.8	0.74	0.9	0.87	0.76	0.7	0.54
3.9	6.9	8.9	27.1	42.2	57.9	60.6	57.4	55.3	60.5	76.5	84.1	85.9	88.5	82.3	79.4	133.7	149.5	229.8	396	464.8	454.5	444.7	464.6	464.5	597.9	623.3	574.6	543.5	534.24	461.74
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	36.37	39.59
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	24.8	0	8.8	8.7	8.8	64.7	69.2	67.6	79	91.1	91.3	86.2	87.9	82	78.3	83.3	92.5	83.2	75.1	67	63.6	67.6	90	80.3	89.5	77	66.7	105.31	74.28
0	0	0	0	147.2	198.5	203.7	114.8	118.8	118.8	112.4	112.4	112.4	112.4	112.4	112.4	112.4	112.4	112.4	112.4	112.4	112.4	115	115	196.6	196.6	203	206.4	206.4	230.77	83.63
3.3	7	17.8	61.3	53.4	95.2	95.9	107.6	92.1	63.1	73.4	85.1	98.2	129.8	136.7	136.7	145.3	115.6	101.5	111.1	127.5	165.5	136.5	164.9	144.1	154	138.1	175.5	244.4	197.9	271.08
0.01	0.01	0.05	0.09	0.25	0.36	0.37	0.34	0.34	0.31	0.34	0.37	0.39	0.42	0.42	0.41	0.47	0.46	0.54	0.7	0.78	0.8	0.76	0.81	0.9	1.03	1.05	1.03	1.06	1.1	0.93
0.06	0.12	0.33	0.41	0.61	0.64	0.59	0.58	0.61	0.59	0.61	0.68	0.66	0.68	0.71	0.75	0.89	0.99	1.12	1.82	1.61	1.51	1.47	1.59	1.69	1.77	1.96	1.91	1.82	1.81	1.47

1.3	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.09	0.09
0	0	137.9	115.1	146.8	119.7	106.3	89	69.8	148.6	165.2	180.8	199.3	209.8	218.9	232.2	256.5	292.2	317.3	397.4	414.4	419.9	439.6	466.3	552.6	557.5	579.8	601.7	613.3	621.85	627.79
0.03	0.06	0.01	0.02	0.16	0.24	0.31	0.34	0.39	0.43	0.48	0.53	0.53	0.55	0.58	0.65	0.75	0.87	1.04	1.33	1.44	1.49	1.56	1.61	1.64	1.73	1.84	1.91	1.94	1.87	1.71
400	-2,900	-41,700	-38,000	-50,300	-55,100	-46,100	-49,500	-69,000	-73,200	-73,200	-68,700	-65,100	-67,800	-70,100	-68,100	-58,500	-62,600	-51,800	-46,200	-51,500	-71,300	-84,100	-66,300	-79,900	-85,300	-64,800	-73,900	-86,500	-100,006	-124,758
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.03	0.06	0.11	0.1	0.25	0.31	0.37	0.38	0.39	0.51	0.57	0.64	0.67	0.69	0.73	0.81	0.95	1.1	1.31	1.69	1.81	1.84	1.91	2.01	2.11	2.2	2.36	2.44	2.47	2.39	2.22
14.2	33.1	52.9	33.3	42.9	37.7	24.9	21.9	18.1	18.8	25.2	20.3	20.8	24.1	20.4	25.3	42.5	32.2	47.9	82.7	34.7	28.8	41.3	50.3	47.6	39	66.2	50	54	43.51	34.88
13.4	5.9	25.3	140.6	92	96.6	63.4	56.5	66.9	87.3	100.6	105.1	110.3	112.5	111.7	124.5	110.5	145.7	205	566.7	294.7	268.4	229.8	261.9	263.8	240.5	352.7	307.9	231.4	185.26	144.34
0	17.5	54.2	0	40.7	18.1	10.8	7	10.8	7.8	6.6	8.9	9.8	3.1	4.1	0	35.7	34.6	28.2	59.6	6.2	42.6	45.2	57.2	58.8	49.8	94	64.3	48.9	75.11	87.39
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	81.5	19.5	14.5	55.9	0	0	0	17.9	18.5	26.8	26.7	31.4	30.2	35.4	27.9	28.6	39	67.8	82.8	67.8	82.7	77.8	69.5	27.5	30	107.5	25	25	30
27.6	56.5	213.9	193.4	190.1	208.3	99.1	85.4	95.8	131.8	150.9	161.1	167.6	171.1	166.4	185.2	216.6	241.1	320.1	776.8	418.4	407.6	399	447.2	439.7	356.8	542.9	529.7	359.3	328.87	296.61
0	0	10	116.7	138.7	89.4	84.9	73.7	81.7	147.5	132.7	123.5	136.2	169.2	158.8	121.1	133	107.9	155	113.9	164.6	181.7	334.2	310.8	361	334.5	313.1	274.1	389.6	487.49	371.86
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	522	345
0	0	0	0	22.9	36.1	40.1	43.4	47.8	21.5	29.9	41.7	42.2	67.8	68.5	66.4	71.5	67.6	59.1	71.8	89.1	90.9	76.8	127.1	111.9	202.5	206.8	189.9	174.8	167.61	148.64
0	0	10	116.7	161.6	125.5	125	117.1	129.5	169	162.6	165.2	178.4	237	227.3	187.5	204.5	175.5	214.1	185.7	253.7	272.6	411	437.9	472.9	537	519.9	464	564.4	655.62	520.85
0.03	0.06	0.22	0.31	0.35	0.33	0.22	0.2	0.23	0.3	0.31	0.33	0.35	0.41	0.39	0.37	0.42	0.42	0.53	0.96	0.67	0.68	0.81	0.89	0.91	0.89	1.06	0.99	0.92	0.98	0.82
0.06	0.12	0.33	0.41	0.61	0.64	0.59	0.58	0.61	0.81	0.88	0.96	1.01	1.1	1.13	1.18	1.37	1.51	1.84	2.65	2.48	2.52	2.72	2.89	3.02	3.09	3.42	3.43	3.39	3.38	3.03

Details

Balance Sheet

ⓘ

What Is the Balance Sheet?

The balance sheet is a financial snapshot of NU Skin Enterprises at a specific point in time. It follows the fundamental equation: Assets = Liabilities + Shareholders' Equity. Unlike the income statement (which covers a period), the balance sheet tells you what the company owns, what it owes, and what belongs to shareholders at a given date.

Assets

Current assets (cash, receivables, inventory) can be converted to cash within 12 months and indicate short-term liquidity. Non-current assets (property, equipment, intangible assets, goodwill) represent long-term investments. A high proportion of cash and short-term investments gives NU Skin Enterprises financial flexibility to weather downturns, fund acquisitions, or return capital to shareholders.

Liabilities

Current liabilities (accounts payable, short-term debt) are obligations due within one year. Non-current liabilities (long-term debt, pension obligations) are due further out. Key ratio to watch: the debt-to-equity ratio (Total Debt ÷ Shareholders' Equity). A ratio below 1.0 is generally healthy, meaning the company is funded more by equity than debt. Highly leveraged companies amplify both gains and losses.

Shareholders' Equity

Equity is the residual value belonging to shareholders after all debts are paid. It includes retained earnings (accumulated profits not paid out as dividends) and paid-in capital. Rising equity year over year is a positive sign — it means NU Skin Enterprises is building book value. Declining equity, especially when driven by losses or heavy share buybacks funded by debt, warrants closer scrutiny.

Key Ratios to Derive

From the balance sheet, you can calculate the current ratio (current assets ÷ current liabilities; above 1.5 is comfortable), book value per share (equity ÷ shares outstanding), and return on equity (net income ÷ equity; above 15 % is strong). Tracking these ratios over time reveals whether NU Skin Enterprises is strengthening or weakening its financial position.

NET INCOME (M USD)

DEPRECIATION AND AMORTIZATION M USDDEPRECIATION (M USD)

DEFERRED TAXES (M USD)

CHANGES IN WORKING CAPITAL (M USD)CHANGES IN WORKING CAPITAL (M USD)

NON-CASH ITEM (M USD)

PAID INTEREST (M USD)

PAID TAXES (M USD)

Net Cash Flow from Operating Activities (M USD)NET CASH FLOW FROM OPERATING ACTIVITIES (M USD)

CAPITAL EXPENDITURES (M USD)

CASH FLOW FROM INVESTING ACTIVITIES (M USD)CASH FLOW FROM INVESTING ACTIVITIES (M USD)

CASH FLOW FROM OTHER INVESTING ACTIVITIES (M USD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M USD)

INTEREST INCOME AND EXPENSES (M USD)

NET DEBT CHANGE (M USD)NET DEBT CHANGE (M USD)

Net change in equity (M USD)NET CHANGE IN EQUITY (M USD)

CASH FLOW FROM FINANCING ACTIVITIES (M USD)CASH FLOW FROM FINANCING ACTIVITIES (M USD)

OTHER ITEMS OF FINANCING CASH FLOWS (M USD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M USD)

TOTAL DIVIDENDS PAID (M USD)

NET CHANGE IN CASH FLOW (M USD)

FREE CASH FLOW (M USD)

SHARE-BASED COMPENSATION (M USD)

1992	1993	1994	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
4	4	17	8	40	84	118	103	86	61	50	64	67	77	74	32	43	65	89	136	153	221	364	189	133	143	129	121	173	191	147	104	8	-146
0	0	1	0	2	9	8	37	29	32	31	21	22	27	30	29	33	30	28	29	32	33	34	54	71	72	71	83	76	74	76	72	70	69
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12	-13	0	4	-41	10	17	-17	39	-14	2	-11	5	-51	-18	-55
9	9	-9	-11	22	31	-56	-43	-89	-55	-6	26	17	24	8	-14	-36	-18	-4	21	-14	33	140	-382	65	28	47	-71	-132	52	-193	-92	-81	-28
0	0	0	1	0	16	38	20	3	5	-1	-1	1	0	0	28	16	32	17	25	67	38	64	88	42	57	34	111	68	97	128	87	154	287
0	0	0	0	0	0	0	3	5	4	2	2	2	4	5	5	7	7	7	6	5	5	4	5	7	11	7	20	17	11	8	14	33	35
0	0	0	0	0	18	73	77	76	30	18	18	26	7	15	19	21	27	36	61	75	95	130	171	49	40	49	123	97	56	96	42	32	30
14	14	9	0	65	142	108	118	30	43	74	111	109	130	114	75	48	103	133	187	224	311	530	-56	322	275	302	202	177	379	141	108	118	111
-4	-4	-1	0	-5	-9	-14	-18	-29	-23	-15	-26	-23	-37	-36	-37	-22	-16	-20	-53	-41	-96	-185	-101	-56	-50	-60	-70	-66	-63	-68	-59	-58	-41
-5	-5	-2	-1	-6	-9	-17	-46	-44	-23	-15	-42	-5	-48	-26	-37	-28	-10	-20	-53	-71	-104	-193	-91	-60	-57	-92	-108	-71	-79	-88	-67	-134	-37
-1	-1	0	0	0	0	-3	-27	-14	0	0	-15	18	-10	10	0	-5	5	0	0	-29	-8	-8	9	-4	-7	-31	-38	-5	-15	-20	-8	-76	3
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
4	4	-4	0	0	-15	-71	-40	-14	-52	0	0	75	-16	12	13	33	-32	-30	-7	-28	73	11	82	0	177	-36	29	-69	-28	38	25	96	-112
0	0	0	0	0	0	-20	-8	-23	-12	-17	-12	-141	-55	-18	-62	-65	-2	-14	-37	-37	-196	-106	-48	-160	-232	-47	-58	-3	-138	-66	-43	-8	-2
4	4	-4	0	-8	5	-110	-48	-73	-65	-33	-32	-88	-94	-30	-74	-57	-62	-73	-69	-107	-163	-120	-41	-235	-134	-159	-116	-154	-245	-104	-99	10	-133
0	0	0	0	-8	100	11	0	-35	0	0	0	0	0	0	1	1	0	1	6	-4	7	45	6	5	0	0	-7	0	0	0	-5	0	-6
0	0	0	0	0	-80	-30	0	0	0	-16	-19	-21	-22	-25	-27	-27	-27	-29	-31	-36	-48	-70	-81	-81	-78	-76	-80	-82	-78	-76	-77	-77	-11
13	13	3	-1	46	130	-40	14	-78	-46	11	28	20	-12	45	-34	-34	27	43	72	42	47	205	-236	1	67	69	-39	-51	67	-63	-74	-8	-69
9.9	9.9	8.1	-1.1	59.6	133.2	94.2	100.3	0.6	20.4	59.3	84.6	85.5	92.5	77.7	38.1	26	87.3	113.7	134.1	182.5	214.4	345.1	-158	265.5	225.1	242.4	132.3	111.8	315.3	73	49	60.15	70.16
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

API Docs Get API Key

NU Skin Enterprises Stock Quarterly Figures

REVENUE (B USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (M USD)

NET INCOME (M USD)

NET INCOME GROWTH (%)

DIVIDEND (USD)DIV. (USD)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

1995 Q3	1995 Q4	1996 Q1	1996 Q2	1996 Q3	1996 Q4	1997 Q1	1997 Q2	1997 Q3	1997 Q4	1998 Q1	1998 Q2	1998 Q3	1998 Q4	1999 Q1	1999 Q2	1999 Q3	1999 Q4	2000 Q1	2000 Q2	2000 Q3	2000 Q4	2001 Q1	2001 Q2	2001 Q3	2001 Q4	2002 Q1	2002 Q2	2002 Q3	2002 Q4	2003 Q1	2003 Q2	2003 Q3	2003 Q4	2004 Q1	2004 Q2	2004 Q3	2004 Q4	2005 Q1	2005 Q2	2005 Q3	2005 Q4	2006 Q1	2006 Q2	2006 Q3	2006 Q4	2007 Q1	2007 Q2	2007 Q3	2007 Q4	2008 Q1	2008 Q2	2008 Q3	2008 Q4	2009 Q1	2009 Q2	2009 Q3	2009 Q4	2010 Q1	2010 Q2	2010 Q3	2010 Q4	2011 Q1	2011 Q2	2011 Q3	2011 Q4	2012 Q1	2012 Q2	2012 Q3	2012 Q4	2013 Q1	2013 Q2	2013 Q3	2013 Q4	2014 Q1	2014 Q2	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4e	2026 Q1e	2026 Q2e	2026 Q3e	2026 Q4e
0.08	0.12	0.12	0.16	0.18	0.21	0.22	0.25	0.24	0.24	0.23	0.21	0.22	0.26	0.23	0.21	0.22	0.23	0.21	0.23	0.22	0.22	0.21	0.22	0.22	0.23	0.22	0.24	0.25	0.25	0.22	0.24	0.25	0.28	0.26	0.28	0.28	0.31	0.29	0.31	0.29	0.29	0.27	0.28	0.28	0.29	0.27	0.29	0.29	0.31	0.3	0.32	0.31	0.32	0.3	0.32	0.33	0.38	0.36	0.39	0.38	0.4	0.4	0.42	0.43	0.47	0.46	0.59	0.53	0.55	0.54	0.67	0.91	1.02	0.67	0.65	0.64	0.61	0.54	0.56	0.57	0.57	0.47	0.6	0.6	0.53	0.5	0.55	0.56	0.67	0.62	0.7	0.68	0.68	0.62	0.62	0.59	0.58	0.52	0.61	0.7	0.75	0.68	0.7	0.64	0.67	0.6	0.56	0.54	0.52	0.48	0.5	0.5	0.49	0.42	0.44	0.43	0.45	0.36	0.39	0.36	0.39	0.33	0.39	0.39	0.4
–	40.96	5.98	31.45	12.27	13.11	8.21	9.38	-0.82	-1.23	-5.42	-7.93	3.83	18.89	-9.69	-9.44	4.27	4.09	-6.99	6.57	-5.29	3.72	-5.83	3.81	2.75	3.57	-6.90	12.96	3.28	-0.79	-12.40	9.59	4.17	10.00	-4.00	7.58	-0.35	8.13	-5.56	7.27	-6.45	–	-8.62	7.17	-2.82	4.71	-5.54	5.13	1.05	5.52	-2.61	7.72	-3.43	2.26	-6.62	8.78	3.73	13.17	-3.70	6.59	-1.29	4.70	-1.50	7.34	0.94	9.81	-1.70	28.35	-11.30	4.56	-1.64	24.03	35.32	11.89	-33.96	-3.13	-1.85	-4.55	-10.84	3.13	1.96	0.18	-17.66	27.39	0.67	-12.09	-6.03	10.22	2.36	18.29	-7.51	14.29	-4.12	1.19	-8.78	–	-5.46	-1.02	-11.15	18.15	14.87	6.40	-9.49	3.99	-8.95	4.99	-10.25	-7.28	-4.11	-2.79	-7.85	3.95	-0.40	-2.01	-14.55	5.28	-2.05	3.49	-18.20	6.04	-5.70	6.04	-13.73	17.42	0.51	1.27
73.49	71.79	71.77	71.78	71.58	71.01	79.91	79.59	79.84	80.42	80.18	72.25	75.58	79.07	82.40	82.94	82.73	83.84	84.04	82.82	82.79	82.51	79.52	80.28	79.46	80.17	79.63	80.33	80.56	80.40	81.28	81.25	82.40	83.64	83.33	83.10	83.04	83.01	82.70	82.58	82.41	82.41	82.26	82.75	82.61	82.01	81.68	82.23	82.07	81.70	81.54	81.62	81.61	81.70	81.76	81.06	81.44	82.28	82.14	82.47	81.98	82.29	74.68	83.25	83.41	82.98	83.55	83.81	83.46	82.73	83.36	83.46	84.58	83.76	84.05	76.00	82.92	82.59	80.66	80.18	73.20	78.67	70.91	78.67	79.14	79.47	77.56	77.82	78.51	77.63	76.14	75.99	76.59	76.28	76.57	75.28	76.23	75.81	75.68	74.84	73.97	73.93	74.74	75.57	75.20	74.15	73.34	73.57	67.78	71.65	72.14	72.80	58.63	72.13	70.50	69.93	70.00	62.70	67.58	68.65	70.33	66.32	76.88	65.47	65.14	64.32
61	84	89	117	131	147	179	195	194	193	182	151	164	204	192	175	182	192	179	188	178	184	167	175	178	186	172	196	203	201	178	195	206	230	220	236	235	254	239	256	239	239	218	235	228	237	223	236	238	250	243	262	253	259	242	261	272	311	299	320	314	330	295	353	357	390	386	497	439	455	451	560	768	851	564	494	529	503	438	449	418	450	334	472	478	422	387	428	442	517	469	535	517	521	477	469	449	442	392	458	520	553	506	532	482	499	443	412	364	374	347	364	292	352	294	307	301	279	246	265	256	256	256	256	256	256
8	12	14	20	25	21	25	30	30	32	33	22	25	22	30	22	21	12	14	15	15	16	12	11	12	13	12	18	15	18	12	16	15	23	14	20	20	22	17	22	17	15	-10	14	13	15	10	13	13	6	13	20	16	14	11	22	25	30	31	32	35	37	15	41	46	49	47	60	54	59	54	74	110	125	54	19	68	46	36	44	16	35	3	44	56	38	27	42	41	18	35	51	53	-17	43	46	44	40	19	41	56	73	47	59	49	-9	38	34	-25	57	11	26	-37	7	0	-118	8	-36	107	21	17	14	7	16	20	19
–	50.00	16.67	42.86	25.00	-16.00	19.05	20.00	–	6.67	3.13	-33.33	13.64	-12.00	36.36	-26.67	-4.55	-42.86	16.67	7.14	–	6.67	-25.00	-8.33	9.09	8.33	-7.69	50.00	-16.67	20.00	-33.33	33.33	-6.25	53.33	-39.13	42.86	–	10.00	-22.73	29.41	-22.73	-11.76	-166.67	-240.00	-7.14	15.38	-33.33	30.00	–	-53.85	116.67	53.85	-20.00	-12.50	-21.43	100.00	13.64	20.00	3.33	3.23	9.38	5.71	-59.46	173.33	12.20	6.52	-4.08	27.66	-10.00	9.26	-8.47	37.04	48.65	13.64	-56.80	-64.81	257.89	-32.35	-21.74	22.22	-63.64	118.75	-91.43	1,366.67	27.27	-32.14	-28.95	55.56	-2.38	-56.10	94.44	45.71	3.92	-132.08	-352.94	6.98	-4.35	-9.09	-52.50	115.79	36.59	30.36	-35.62	25.53	-16.95	-118.37	-522.22	-10.53	-173.53	-328.00	-80.70	136.36	-242.31	-118.92	–	–	-106.78	-550.00	-397.22	-80.37	-19.05	-17.65	-50.00	128.57	25.00	-5.00
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.05	0.05	0.05	0.05	0.06	0.06	0.06	0.06	0.07	0.07	0.07	0.07	0.08	0.08	0.08	0.08	0.09	0.09	0.09	0.09	0.10	0.10	0.10	0.10	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.12	0.12	0.12	0.12	0.13	0.13	0.13	0.13	0.14	0.14	0.16	0.16	0.20	0.20	0.20	0.20	0.30	0.30	0.30	0.30	0.35	0.35	0.35	0.35	0.35	0.35	0.35	0.35	0.36	0.36	0.36	0.36	0.36	0.36	0.36	0.36	0.37	0.37	0.37	0.37	0.37	0.37	0.37	0.37	0.38	0.38	0.38	0.38	0.38	0.38	0.38	0.38	0.39	0.39	0.39	0.39	0.39	0.39	0.39	0.39	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	-	-	-	-
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	20.00	–	–	–	16.67	–	–	–	14.29	–	–	–	12.50	–	–	–	11.11	–	–	–	–	–	–	–	10.00	–	–	–	9.09	–	–	–	8.33	–	–	–	7.69	–	14.29	–	25.00	–	–	–	50.00	–	–	–	13.33	–	–	–	2.94	–	–	–	–	–	–	–	2.86	–	–	–	–	–	–	–	2.78	–	–	–	2.70	–	–	–	–	–	–	–	2.63	–	–	–	–	–	–	–	-84.62	–	–	–	–	–	–	–	–	–	–	–
84.4	84.4	80.5	80.5	80.5	80.5	87.4	87.4	87.4	87.2	86.3	87.3	86.2	88.4	89.2	88.4	88	86.5	87.2	86.2	85.4	84.8	84.9	84.2	83.5	83.3	83.2	83.6	83	82.8	82.2	81.6	81.7	74.6	72.5	73.7	72.6	71.2	71.4	71.5	71.6	71.1	70.1	71.1	70.6	68.7	66.8	65.3	67.5	64.9	64.2	64.3	64.2	63.7	63.5	63.7	63.9	65.1	64.8	65.1	64.1	64.4	64	64.2	64.7	65.3	65	64.2	62.1	60.8	60.6	61.1	61.5	62.1	61.2	61.1	60.8	60.5	60.3	59.7	58.7	57.5	56.4	56.4	57.9	54.6	54.1	54.8	54.8	55.9	56	56.7	56.7	55.5	56.1	55.9	55.8	55.9	55.1	51.9	52.2	52.3	52.2	51.6	51.3	49.9	51.1	51	50.2	49.6	50.1	50.2	49.9	52.01	49.54	49.69	49.73	49.71	50.33	49.5	50.31	50.31	50.31	50.31	50.31	50.31

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Gross Margin

EBIT and EBIT Margin

Net Income and Earnings Per Share (EPS)

Shares Outstanding

Analyst Estimates

API Docs Get API Key

NU Skin Enterprises stock margins

The NU Skin Enterprises margin analysis displays the gross margin, EBIT margin, as well as the profit margin of NU Skin Enterprises. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for NU Skin Enterprises.

3 Years
5 Years
10 Years
25 Years
Max

Gross margin

EBIT margin

Profit margin

Details

API Docs Get API Key

NU Skin Enterprises Stock Sales Revenue, EBIT, Earnings per Share

The NU Skin Enterprises earnings per share therefore indicates how much revenue NU Skin Enterprises has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Sales per Share

EBIT per share

Earnings per Share

Details

API Docs Get API Key

NU Skin Enterprises business model

NU Skin Enterprises Inc is a multinational company that was founded in 1984. It is based in Provo, Utah, USA, and operates in the fields of nutrition, skincare, and anti-aging. NU Skin is a direct sales and multi-level marketing company that sells its products through a variety of distribution channels. The company operates in over 50 countries and has more than one million independent distributors.

API Docs Get API Key

NU Skin Enterprises SWOT Analysis

Strengths

NU Skin Enterprises Inc has a strong global presence, allowing it to target a diverse customer base in various countries. Its extensive product portfolio, which includes skincare, personal care, and nutritional supplements, offers a competitive advantage in the beauty and wellness industry. The company's focus on innovative research and development also enables it to introduce new products and stay ahead of competitors.

NU Skin Enterprises Inc has a robust direct selling model, which provides opportunities for individuals to become independent distributors and generate income. This business model facilitates a strong network of sales representatives, enhancing the company's market reach and brand recognition.

NU Skin Enterprises Inc heavily relies on its direct selling strategy, which could be a potential weakness as changing market dynamics and consumer preferences may impact its sales model. Moreover, the intense competition in the beauty and wellness industry poses a challenge to maintain market share.

The company's dependency on the Asia-Pacific region for a significant portion of its revenue makes it vulnerable to economic and political challenges specific to that area, which may impact its overall financial performance.

With the growing consumer interest in health and wellness, NU Skin Enterprises Inc can capitalize on the increasing demand for natural and organic products. Expanding into untapped markets and diversifying its product offerings to align with emerging trends can provide new revenue streams.

The expansion of e-commerce and online sales channels presents an opportunity for NU Skin Enterprises Inc to reach a wider customer base and improve its accessibility. Utilizing social media platforms and digital marketing strategies can further enhance brand visibility and engagement with potential customers.

NU Skin Enterprises Inc faces the threat of stricter regulations and compliance requirements in the direct selling industry. Changes in government policies and legal frameworks may disrupt the operations and impact the company's profitability.

Negative publicity or controversies related to product quality or business practices can significantly damage NU Skin Enterprises Inc's reputation and consumer trust. The company should proactively manage and address any potential risks in order to maintain its brand image.

Weaknesses

Opportunities

Threats

API Docs Get API Key

NU Skin Enterprises Segments

NU Skin Enterprises Revenue by Segment (1/3)

3 Years
5 Years
Max

The product line for premium-quality personal care products

Personal care products developed and distributed under the Nu Skin brand

The name of the product line for which the entity reported revenue from external customers during the period

Nu Skin

The product line for science-based nutritional supplements

Pharmanex

Wellness products developed and distributed under the Pharmanex brand

Beauty products developed and distributed under the Nu Skin brand

Other products and services, including household products and technology services

Other Product Lines

Other product lines for which the entity reported revenue from external customers during the period

Details

NU Skin Enterprises Revenue by Segment (2/3)

3 Years
Max

Other

Details

NU Skin Enterprises Revenue by Segment (3/3)

3 Years
5 Years
Max

Other

Details

NU Skin Enterprises Revenue by Region

3 Years
5 Years
10 Years
Max

China, Hong Kong, Macau and Taiwan as a unity

All other countries excluding the United States, Mainland China, South Korea and Japan

Mainland China

A subregion of Asia, consisting of Siberia and Russian Far East in the Asian portion of Russia - the area east of the Ural Mountains

Consists of Australia, Canada, Latin America, New Caledonia, New Zealand and the United States

South Korea

Americas

United States

Consists of Australia, Brunei, French Polynesia, Indonesia, Malaysia, New Caledonia, New Zealand, the Philippines, Singapore, Thailand and Vietnam

A component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements

The country of domicile about which segment information is provided by the entity

Japan

A specified foreign country about which segment information is provided by the entity

Consists of Hong Kong and Taiwan

A significant area of a specified group of foreign countries about which segment information is provided by the entity

EMEA

Hong Kong

Europe

Malaysia

Taiwan

Includes the manufacturing and product-packaging companies that the Company acquired during the first quarter of 2018, as well as the Company's indoor growing technology initiative

Details

Date

China, Hong Kong, Macau and Taiwan as a unity

All other countries excluding the United States, Mainland China, South Korea and Japan

Mainland China

A subregion of Asia, consisting of Siberia and Russian Far East in the Asian portion of Russia - the area east of the Ural Mountains

Consists of Australia, Canada, Latin America, New Caledonia, New Zealand and the United States

South Korea

Americas

United States

Consists of Australia, Brunei, French Polynesia, Indonesia, Malaysia, New Caledonia, New Zealand, the Philippines, Singapore, Thailand and Vietnam

A component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements

The country of domicile about which segment information is provided by the entity

Japan

A specified foreign country about which segment information is provided by the entity

Consists of Hong Kong and Taiwan

A significant area of a specified group of foreign countries about which segment information is provided by the entity

EMEA

Hong Kong

Europe

Malaysia

Taiwan

Includes the manufacturing and product-packaging companies that the Company acquired during the first quarter of 2018, as well as the Company's indoor growing technology initiative

Jan 1, 2011

0 USD

152.54 M USD

0 USD

278.65 M USD

0 USD

211.79 M USD

0 USD

472.52 M USD

0 USD

80.52 M USD

140.5 M USD

0 USD

108.86 M USD

0 USD

Jan 1, 2012

0 USD

169.73 M USD

230.92 M USD

0 USD

497.3 M USD

0 USD

162.06 M USD

0 USD

Jan 1, 2013

0 USD

268.23 M USD

0 USD

199.16 M USD

0 USD

158.63 M USD

0 USD

128.66 M USD

0 USD

Jan 1, 2014

0 USD

675.08 M USD

0 USD

467.72 M USD

329.03 M USD

230.77 M USD

0 USD

948.52 M USD

0 USD

315.27 M USD

0 USD

180.57 M USD

0 USD

Jan 1, 2015

771.67 M USD

0 USD

565.53 M USD

686.56 M USD

0 USD

422.34 M USD

329.67 M USD

243.75 M USD

0 USD

321.97 M USD

0 USD

264.21 M USD

0 USD

137.19 M USD

0 USD

Jan 1, 2016

794.39 M USD

0 USD

610.41 M USD

692.74 M USD

0 USD

413.7 M USD

276.59 M USD

201.24 M USD

0 USD

296.76 M USD

0 USD

279.04 M USD

0 USD

147.32 M USD

0 USD

Jan 1, 2017

0 USD

725.6 M USD

716.99 M USD

0 USD

361.69 M USD

317.38 M USD

218.73 M USD

299.98 M USD

0 USD

256.09 M USD

0 USD

166.7 M USD

0 USD

160.28 M USD

0 USD

Jan 1, 2018

0 USD

385.03 M USD

373.36 M USD

0 USD

311.44 M USD

0 USD

254.94 M USD

0 USD

94.03 M USD

API Docs Get API Key

NU Skin Enterprises Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

API Docs Get API Key

NU Skin Enterprises historical P/E ratio, EBIT multiple, and P/S ratio

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides NU Skin Enterprises's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates NU Skin Enterprises's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots NU Skin Enterprises's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if NU Skin Enterprises grows earnings faster than its peers.

API Docs Get API Key

NU Skin Enterprises annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

API Docs Get API Key

NU Skin Enterprises shares outstanding

The number of shares was NU Skin Enterprises in 2025 — This indicates how many shares 49.662 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Number of stocks

Details

API Docs Get API Key

NU Skin Enterprises Dividend History

26 years of dividend payments

YearAnnual DividendYoY ChangePayments

20260.06USDYTD—1×

Feb 27, 20260.06USD 0.0%1/1

20250.24USD 0.0%4×

Feb 24, 20250.06USD 0.0%1/4

May 30, 20250.06USD 0.0%2/4

Aug 29, 20250.06USD 0.0%3/4

Nov 28, 20250.06USD 0.0%4/4

20240.24USD↓ 84.6%4×

20231.56USD↑ 1.3%4×

20221.54USD↑ 1.3%4×

20211.52USD↑ 1.3%4×

20201.5USD↑ 1.4%4×

20191.48USD↑ 1.4%4×

20181.46USD↑ 1.4%4×

20171.44USD↑ 1.4%4×

API Docs Get API Key

NU Skin Enterprises dividend history and estimates

In 2025, NU Skin Enterprises paid a dividend amounting to 0.24 USD. Dividend means that NU Skin Enterprises distributes a portion of its profits to its owners.

3 Years
5 Years
10 Years
25 Years
Max

Dividend

Dividend (Estimate)

Details

API Docs Get API Key

NU Skin Enterprises dividend payout ratio

In 2025, NU Skin Enterprises had a payout ratio of 63.99%. The payout ratio indicates the percentage of the company's profits that NU Skin Enterprises distributes as dividends.

3 Years
5 Years
10 Years
25 Years
Max

Payout ratio

Details

API Docs Get API Key

Current NU Skin Enterprises forecasts and price targets in March 2026

Δ MOM Price Target	null %
Buy	null % (0)
Hold	44.44 % (4)
Sell	55.56 % (5)
12M Price Target	7.65
Last Price	10.38
Currency	USD
12M Return Potential	-26.32 %
LTM Return	0 %

API Docs Get API Key

NU Skin Enterprises Earnings Estimates

Date	EPS estimate	Revenue Estimate	Quarterly report
2/12/2026	0.3USD	386.53 MUSD	2025 Q4
8/7/2025	0.25USD	380.44 MUSD	2025 Q2
5/1/2024	0.33USD	489.29 MUSD	2024 Q1
2/13/2024	0.28USD	473.29 MUSD	2023 Q4
8/2/2023	0.82USD	582.93 MUSD	2023 Q2
5/2/2023	0.77USD	551.79 MUSD	2023 Q1
2/14/2023	0.55USD	548.52 MUSD	2022 Q4
11/2/2022	0.79USD	578.36 MUSD	2022 Q3
8/4/2022	0.76USD	588.04 MUSD	2022 Q2
5/4/2022	0.73USD	588.39 MUSD	2022 Q1
2/16/2022	0.96USD	665.77 MUSD	2021 Q4
11/3/2021	0.87USD	649.47 MUSD	2021 Q3
8/4/2021	1.06USD	713.17 MUSD	2021 Q2
5/5/2021	0.73USD	644.94 MUSD	2021 Q1
2/10/2021	1.2USD	760.98 MUSD	2020 Q4
11/4/2020	0.99USD	699.93 MUSD	2020 Q3
8/5/2020	0.63USD	592.71 MUSD	2020 Q2
5/6/2020	0.26USD	488.04 MUSD	2020 Q1
2/12/2020	0.73USD	590.75 MUSD	2019 Q4
11/5/2019	0.77USD	616.34 MUSD	2019 Q3
8/6/2019	0.84USD	631.77 MUSD	2019 Q2
4/30/2019	0.72USD	625.08 MUSD	2019 Q1
2/13/2019	1.06USD	688.29 MUSD	2018 Q4
11/7/2018	0.98USD	675.83 MUSD	2018 Q3
8/2/2018	0.92USD	653.91 MUSD	2018 Q2
4/26/2018	0.7USD	568.06 MUSD	2018 Q1
2/15/2018	1.2USD	675.42 MUSD	2017 Q4
11/1/2017	0.77USD	570.51 MUSD	2017 Q3
8/2/2017	0.7USD	555.89 MUSD	2017 Q2
5/3/2017	0.5USD	498.92 MUSD	2017 Q1
2/16/2017	0.8USD	561.49 MUSD	2016 Q4
11/3/2016	0.85USD	593.87 MUSD	2016 Q3
8/4/2016	0.8USD	590.35 MUSD	2016 Q2
4/28/2016	0.38USD	472.48 MUSD	2016 Q1
2/11/2016	0.74USD	594.71 MUSD	2015 Q4
10/29/2015	0.85USD	579.94 MUSD	2015 Q3
8/6/2015	0.72USD	559.07 MUSD	2015 Q2
5/6/2015	0.74USD	552.81 MUSD	2015 Q1
2/5/2015	0.83USD	608.88 MUSD	2014 Q4
11/5/2014	0.93USD	638.69 MUSD	2014 Q3
8/6/2014	1.28USD	719.67 MUSD	2014 Q2
5/6/2014	0.95USD	666.67 MUSD	2014 Q1
3/3/2014	2.01USD	1.08 BUSD	2013 Q4
10/22/2013	1.43USD	825.63 MUSD	2013 Q3
8/1/2013	1.21USD	690.48 MUSD	2013 Q2
5/2/2013	0.8USD	513.89 MUSD	2013 Q1
2/6/2013	0.94USD	588.19 MUSD	2012 Q4
10/31/2012	0.78USD	487.93 MUSD	2012 Q3
7/26/2012	0.84USD	518.83 MUSD	2012 Q2
4/26/2012	0.71USD	453.7 MUSD	2012 Q1
2/2/2012	0.73USD	487.99 MUSD	2011 Q4
10/25/2011	0.62USD	421.63 MUSD	2011 Q3
8/2/2011	0.6USD	412.61 MUSD	2011 Q2
5/4/2011	0.53USD	396.88 MUSD	2011 Q1
2/2/2011	0.54USD	403.5 MUSD	2010 Q4
11/2/2010	0.49USD	367.56 MUSD	2010 Q3
7/28/2010	0.46USD	375.29 MUSD	2010 Q2
4/28/2010	0.42USD	347.27 MUSD	2010 Q1
2/4/2010	0.4USD	368.02 MUSD	2009 Q4
10/29/2009	0.41USD	339.18 MUSD	2009 Q3
7/29/2009	0.3USD	313.69 MUSD	2009 Q2
4/30/2009	0.24USD	302.19 MUSD	2009 Q1
2/6/2009	0.27USD	315.84 MUSD	2008 Q4
10/29/2008	0.32USD	313.24 MUSD	2008 Q3
7/31/2008	0.29USD	309.95 MUSD	2008 Q2
5/1/2008	0.24USD	289.83 MUSD	2008 Q1
2/6/2008	0.26USD	303.34 MUSD	2007 Q4
11/5/2007	0.23USD	291.08 MUSD	2007 Q3
8/2/2007	0.24USD	292.54 MUSD	2007 Q2
5/3/2007	0.16USD	270.65 MUSD	2007 Q1
2/7/2007	0.21USD	285.07 MUSD	2006 Q4
11/2/2006	0.19USD	277.02 MUSD	2006 Q3
7/31/2006	0.19USD	278.97 MUSD	2006 Q2
5/3/2006	0.15USD	271.92 MUSD	2006 Q1
2/8/2006	0.22USD	294.52 MUSD	2005 Q4
10/27/2005	0.26USD	294.22 MUSD	2005 Q3
7/27/2005	0.31USD	308.19 MUSD	2005 Q2
4/27/2005	0.22USD	287.32 MUSD	2005 Q1
2/8/2005	0.29USD	295.84 MUSD	2004 Q4
10/26/2004	0.27USD	285.08 MUSD	2004 Q3
7/27/2004	0.28USD	279 MUSD	2004 Q2
4/21/2004	0.18USD	245.43 MUSD	2004 Q1
2/5/2004	0.31USD	278.96 MUSD	2003 Q4
10/23/2003	0.22USD	247.74 MUSD	2003 Q3
7/29/2003	0.2USD	228.81 MUSD	2003 Q2
4/22/2003	0.16USD	239.86 MUSD	2003 Q1
2/6/2003	0.22USD	255 MUSD	2002 Q4
10/23/2002	0.19USD	253.75 MUSD	2002 Q3
7/17/2002	0.2USD	0USD	2002 Q2
4/29/2002	0.15USD	0USD	2002 Q1

...

EESG©

Eulerpool ESG Scorecard© for the NU Skin Enterprises stock

47/100

Environment

Social

Governance

Environment

Scope 1 - Direct Emissions—

Scope 2 - Indirect emissions from purchased energy—

Scope 3 - Indirect emissions within the value chain—

Total CO₂ emissions—

CO₂ reduction strategy

Coal energy

Nuclear power

Animal experiments

Fur & Leather—

Pesticides—

Palm Oil—

Tobacco

Genetically modified organisms

Climate concept—

Sustainable forestry—

Recycling regulations

Environmentally friendly packaging

Hazardous substances

Fuel consumption and efficiency

Water consumption and efficiency

Social

Percentage of female employees59.1

Percentage of women in management—

Percentage of Asian employees—

Share of Asian management—

Percentage of Hispanic/Latino employees—

Hispano/Latino Management share—

Percentage of Black employees—

Black Management Share—

Percentage of white employees—

White Management Share—

Adult content

Alcohol

Weapons—

Firearms

Gambling

Military contracts

Human rights concept

Privacy concept—

Occupational health and safety

Catholic

Governance (Corporate Governance)

Environmental reporting

Stakeholder Engagement

Call Back Policies

Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

API Docs Get API Key

NU Skin Enterprises shareholders

%	Name	Stocks	Change	Date
8.21118%	The Vanguard Group, Inc.	4,002,951	-15,689	6/30/2025
7.07208%	BlackRock Institutional Trust Company, N.A.	3,447,640	-134,627	6/30/2025
4.11853%	D. E. Shaw & Co., L.P.	2,007,781	-375,469	6/30/2025
3.67220%	Renaissance Technologies LLC	1,790,199	-43,497	6/30/2025
3.55817%	Prescott Group Capital Management, LLC	1,734,608	+340,000	6/30/2025
3.36404%	Charles Schwab Investment Management, Inc.	1,639,968	+587,584	6/30/2025
3.22500%	Two Sigma Investments, LP	1,572,188	+11,140	6/30/2025
2.50838%	American Century Investment Management, Inc.	1,222,833	+274,123	6/30/2025
2.41036%	Geode Capital Management, L.L.C.	1,175,049	+21,276	6/30/2025
2.15631%	State Street Investment Management (US)	1,051,201	-7,561	6/30/2025
2.04026%	Dimensional Fund Advisors, L.P.	994,626	+270,622	6/30/2025
1.82720%	Castleknight Management LP	890,761	+512,500	6/30/2025
1.35520%	Hillsdale Investment Management Inc.	660,660	+632,110	6/30/2025
1.18235%	PGIM Quantitative Solutions LLC	576,397	+281,785	6/30/2025
1.12884%	Parametric Portfolio Associates LLC	550,309	-281,568	6/30/2025
1.06940%	Goldman Sachs Asset Management, L.P.	521,332	-566,490	6/30/2025
1.04824%	Aristotle Capital Boston, LLC	511,017	-17,253	6/30/2025
1.00520%	Mellon Investments Corporation	490,036	+5,971	6/30/2025
0.99803%	J.P. Morgan Securities LLC	486,540	+55,887	6/30/2025
0.82295%	Northern Trust Investments, Inc.	401,187	-24,417	6/30/2025
0.81362%	Connor, Clark & Lunn Investment Management Ltd.	396,639	+136,511	6/30/2025
0.73241%	Napierski (Ryan S)	357,052	-254,102	4/1/2025
0.72760%	Morgan Stanley & Co. LLC	354,703	-80,295	6/30/2025
0.71517%	BNP Paribas Securities Corp. North America	348,646	+9,052	6/30/2025
0.68403%	Morgan Stanley Investment Management Inc. (US)	333,465	+333,465	6/30/2025
0.67317%	Qube Research & Technologies Ltd	328,171	-222,031	6/30/2025
0.63098%	AQR Capital Management, LLC	307,604	-42,753	6/30/2025
0.61293%	Nuveen LLC	298,802	+113,689	6/30/2025
0.60125%	Tudor Investment Corporation	293,108	-11,001	6/30/2025
0.54414%	Acadian Asset Management LLC	265,267	+161,418	6/30/2025
0.52860%	BlackRock Financial Management, Inc.	257,692	-12,847	6/30/2025
0.50870%	Numeric Investors LLC	247,992	+167,902	6/30/2025
0.49879%	Federated MDTA LLC	243,158	-171,721	6/30/2025
0.48813%	State of Wisconsin Investment Board	237,964	+51,011	6/30/2025
0.44751%	Pacer Advisors, Inc.	218,163	-267,419	9/30/2025
0.44262%	Goldman Sachs & Company, Inc.	215,779	-4,599	6/30/2025
0.44128%	Bridgeway Capital Management, LLC	215,124	+165,124	6/30/2025
0.40617%	Segall Bryant & Hamill, LLC	198,006	+198,006	6/30/2025
0.39905%	Aperio Group, LLC	194,538	-318,717	6/30/2025
0.39316%	Susquehanna International Group, LLP	191,665	-377,404	6/30/2025
0.38563%	Epoch Investment Partners, Inc.	187,995		7/31/2025
0.35549%	BofA Global Research (US)	173,302	-176,011	6/30/2025
0.34742%	Cubist Systematic Strategies, LLC	169,366	-324,735	6/30/2025
0.33842%	BlackRock Investment Management, LLC	164,979	+25,450	6/30/2025
0.32713%	Walleye Capital LLC	159,478	-175,435	6/30/2025
0.31649%	J.P. Morgan Mansart Management Limited	154,287	+2,980	6/30/2025
0.30249%	Barclays Bank PLC	147,465	+32,506	6/30/2025
0.29860%	Engineers Gate Manager, L.P.	145,569	-28,235	6/30/2025
0.29237%	SEI Investments Management Corporation	142,528	+13,497	6/30/2025
0.28230%	Martingale Asset Management, L.P.	137,621	+31,434	6/30/2025
0.25845%	Campbell (Daniel Wayne)	125,992	-9,046	8/29/2025
0.25372%	Inspire Investing	123,690	+74,896	9/30/2025
0.24453%	Lund (Steven J.)	119,210		4/1/2025
0.23481%	Vanguard Investments Australia Ltd.	114,469		6/30/2025
0.22830%	Wellington Management Company, LLP	111,298		7/31/2025
0.22426%	Range Financial Group LLC	109,326	+75,248	9/30/2025
0.21544%	WEDGE Capital Management, L.L.P.	105,026	+105,026	9/30/2025
0.20538%	ETF Architect	100,124	+100,124	6/30/2025
0.20537%	JP Morgan Asset Management	100,116	+7,515	6/30/2025
0.19974%	Caption Management, LLC	97,375	+97,375	6/30/2025
0.19911%	HSBC Global Asset Management (UK) Limited	97,066	+12,040	6/30/2025
0.19312%	Dimensional Fund Advisors, Ltd.	94,148	+3,202	9/30/2025
0.19045%	BNY Mellon Asset Management	92,846	+625	6/30/2025
0.18438%	Thomas Pisano R	89,884	+18,008	6/2/2025
0.18301%	Millennium Management LLC	89,217	-107,835	6/30/2025
0.17641%	XTX Markets LLC	86,000	+11,244	6/30/2025
0.16891%	SummerHaven Investment Management, LLC	82,344	+2,484	6/30/2025
0.16790%	Janney Montgomery Scott LLC	81,852	+81,852	9/30/2025
0.16577%	Ritholtz Wealth Management LLC	80,813	+80,813	9/30/2025
0.16435%	Rhumbline Advisers Ltd. Partnership	80,119	+2,856	6/30/2025
0.15668%	Franklin Advisers, Inc.	76,383	+47,868	6/30/2025
0.14909%	JPMorgan Asset Management (Europe) S.à.r.l.	72,681	+25,193	9/30/2025
0.14805%	Pisano (Thomas)	72,176	+11,330	4/1/2025
0.14794%	EP Wealth Advisors, LLC	72,121		6/30/2025
0.14695%	Hatchett (Steven Keith)	71,640	+6,500	5/28/2025
0.14631%	Graham Capital Management, L.P.	71,325	-45,778	6/30/2025
0.14063%	Jane Street Capital, L.L.C.	68,557	-103,209	6/30/2025
0.13816%	Arrowstreet Capital, Limited Partnership	67,353	+35,369	6/30/2025
0.13129%	T. Rowe Price International Ltd	64,006	+1,313	6/30/2025
0.12638%	Verition Fund Management LLC	61,611	+31,338	6/30/2025
0.12539%	LPL Financial LLC	61,127	+61,127	6/30/2025
0.12439%	PIMCO (US)	60,640	+60,640	6/30/2025
0.12083%	Invesco Capital Management LLC	58,903	-4,756	6/30/2025
0.11817%	Nebula Research & Development LLC	57,608	-9,133	6/30/2025
0.11610%	UBS Financial Services, Inc.	56,597	-73,636	6/30/2025
0.11227%	Los Angeles Capital Management LLC	54,730	+19,625	9/30/2025
0.10965%	Campbell & Company, Inc.	53,452	+27,936	9/30/2025
0.10605%	State Teachers Retirement System of Ohio	51,700	-17,700	9/30/2025
0.10544%	AllianceBernstein L.P.	51,400		6/30/2025
0.10462%	Algert Global LLC	51,000	-41,830	6/30/2025
0.10048%	Versor Investments LP	48,985	+7,900	6/30/2025
0.09815%	Trexquant Investment LP	47,849	-264,945	6/30/2025
0.09675%	Clark (Chayce David)	47,167	-20,000	9/3/2025
0.09498%	State of Wyoming	46,303	-1,408	6/30/2025
0.09310%	Jump Financial, LLC	45,386	-50,782	6/30/2025
0.09114%	First Trust Advisors L.P.	44,430	+3,546	6/30/2025
0.09084%	Research Affiliates, LLC	44,283	+44,283	6/30/2025
0.08998%	Quinn Opportunity Partners LLC	43,866		6/30/2025
0.08487%	Kapitalo Investimentos Ltda	41,372	+41,372	6/30/2025
0.08467%	Woodbury (Edwina D)	41,276	+9	9/10/2025

...

API Docs Get API Key

NU Skin Enterprises Executives and Management Board

Mr. Ryan Napierski

(51)

President, Chief Executive Officer, Director · since 2015

Compensation5.99 MUSD

Compensation5.99 M USD

Mr. Chayce Clark

(42)

Executive Vice President, General Counsel

3.46 MUSD

Compensation3.46 M USD

Mr. James Thomas

(46)

Chief Financial Officer, Executive Vice President

2.51 MUSD

Compensation2.51 M USD

Mr. Steven Hatchett

(53)

Executive Vice President, Chief Product Officer

1.6 MUSD

Compensation1.6 M USD

Mr. Justin Keisel

(51)

Executive Vice President and President of Global Sales

973,618USD

Compensation973,618 USD

API Docs Get API Key

NU Skin Enterprises Research

Soon

Deep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.

Research reports are coming soon

We're building institutional-grade equity research for NU Skin Enterprises and thousands of other companies.

Most common questions regarding NU Skin Enterprises

NU Skin Enterprises Inc is a direct selling company that operates in the personal care and wellness industry. Their business model revolves around offering a wide range of skincare and nutritional products to consumers through a network of independent distributors. NU Skin focuses on selling their products directly to individuals, allowing them to build their own businesses and establish customer relationships. By utilizing this direct selling approach, NU Skin Enterprises Inc aims to provide customers with high-quality products while also offering individuals the opportunity to generate income and achieve financial independence.

API Docs Get API Key

Fair ValuePRO

6.01 USD

Over-/UndervaluationPRO

21.0% undervalued

Expected Return

4.52 %

Sector

Non-cyclical consumption

Industry

Personal Products

Number of shares

48,750,000

Employees

4,900

Revenue per Employee

353,486.53 USD

Revenue growth Ø5 years

-7.67 %

EBIT growth Ø5 years

-27.73 %

Net Income growth Ø5 years

—

Website nuskin.com

Country

United States 🇺🇸

Currency

USD

Initial public offering

Nov 22, 1996

ISIN

US67018T1051

Cusip

67018T105

Sedol

2616870

Market capitalization

407.55 M USDSmall Cap

52-Week Range

7.28–10.21USD

NU Skin Enterprises Directors Dealings

Quality Investing

Details

1 / 10

Sales growth (10Y) > 5%

Revenue growth (3Y) > 5 %

EBIT growth (10Y) > 5%

EBIT growth (3Y) > 5 %

Net debt < 4x EBIT

Profitable since 10Y+

EBIT Drawdown (10Y) < 50%

Return on Equity (ROE) > 15%

ROCE > 15%

Return Expectation > 10%

PEG

—

P/E ratio

-2.45

P/Ee 2025

5.61

P/Ee 2026

5.14

P/Ee 2027

—

P/S

0.21

P/Se

0.24

EV/EBIT

12.26

P/B Ratio

0.63

ROE (Return on Equity)

-22.5 %

ROA (Return on Assets)

-9.98 %

ROCE (Return on Capital Employed)

7.79 %

ROIC (Return on Invested Capital)

-16.92 %

Gross Margin

68.23 %

EBIT Margin

2.93 %

Net Margin

-8.46 %

EPS (Earnings Per Share)

-2.95 USD

Net Debt / EBIT

4.23

Debt/Equity

0.62

Dividend

0.24 USD

Dividend yield

3.32 %

Est. Dividend Yield

0.83 %

Payout Ratio

61.28 %

Dividend growth Ø5Y

-30.87 %

Dividend payments per year

Dividend paid since

25 years+

Dividend not reduced since

1 year

Dividend increased since

0 years

Dividend withholding tax

30 %

Last updated Mar 12, 2026, 10:01 AM

NU Skin Enterprises Peer Group

USANA Health Sciences Inc

Edgewell Personal Care Co

Interparfums Inc

Coty Inc

Medifast Inc

Estee Lauder Companies Inc

NU Skin Enterprises Ticker

DÜSSELDORF · NUS.DUFRANKFURT · NUS.FMUNICH · NUS.MUNEW YORK · NUSSIX · NUS.SW

NU Skin Enterprises FIGI

NUS:US · BBG000HG21Y3NUS:UA · BBG000HG23B4NUS:UC · BBG000HG2477NUS:UN · BBG000HG2681NUS:UP · BBG000HG26P2NUS:UB · BBG000HG2878NUS:UT · BBG000HG28Y8NUS:UM · BBG000HG29M9NUS:UX · BBG000HG3CK3NUS:UD · BBG000HG3K43NUS:UF · BBG000HG3MX7NUS:VY · BBG000HG4QB1NUS:VJ · BBG000HG4QP6NUS:VK · BBG000HG4RS1NUS:GR · BBG000JFGPQ4NUS:GF · BBG000JFGPZ4NUS:GD · BBG000JFGQS0NUS:GS · BBG000JFGRW3NUS:GM · BBG000JFGS33NUS:GB · BBG000JFGSQ8NUS:QT · BBG0077H4X02NUSCHF:EO · BBG007F5XRY3NUSCHF:XH · BBG007F5XS26NUSCHF:XF · BBG007F5XS53NUSCHF:XE · BBG007F5XSS8NUSCHF:XJ · BBG007F5XT42NUSCHF:XL · BBG007F5XTD2NUSCHF:XG · BBG007F5XV29NUSCHF:XO · BBG007F5XV74NUSCHF:XS · BBG007F5XW63NUSCHF:XA · BBG007F5XW90NUSCHF:E1 · BBG007F5XWH1NUSCHF:XT · BBG007F5XWS9NUSCHF:XW · BBG007F5XWY2NUSCHF:XU · BBG007F5XX07NUSCHF:XV · BBG007F5XXF1NUSCHF:EU · BBG007F5XXV3NUS:SW · BBG007FJP1L3NUS:BW · BBG007FJP1S6NUS:VF · BBG00DJDGYW5NUS:GZ · BBG00FGX22Q1NUSCHF:XX · BBG00JN89443NUSUSD:X2 · BBG00JS02HB5NUSUSD:XB · BBG00JS02HC4NUSUSD:XH · BBG00JS02HF1NUSUSD:XF · BBG00JS02HH9NUSUSD:XE · BBG00JS02HK5NUSUSD:XJ · BBG00JS02HL4NUSUSD:XL · BBG00JS02HM3NUSUSD:XG · BBG00JS02HN2NUSUSD:XO · BBG00JS02HP0NUSUSD:XS · BBG00JS02HT6NUSUSD:XA · BBG00JS02HV3NUSUSD:E1 · BBG00JS02HW2NUSUSD:XT · BBG00JS02HX1NUSUSD:XW · BBG00JS02HY0NUSUSD:XU · BBG00JS02HZ9NUSUSD:XV · BBG00JS02J03NUSUSD:XM · BBG00JS02J12NUSUSD:XQ · BBG00JS02J30NUSUSD:XX · BBG00JS02J49NUSUSD:XZ · BBG00JS02J58NUSUSD:EU · BBG00JS02J76NUS2EUR:X2 · BBG00JVLCDD1NUS2EUR:XB · BBG00JVLCDF9NUS2EUR:XH · BBG00JVLCDH7NUS2EUR:XF · BBG00JVLCDK3NUS2EUR:XE · BBG00JVLCDM1NUS2EUR:XJ · BBG00JVLCDN0NUS2EUR:XL · BBG00JVLCDP8NUS2EUR:XG · BBG00JVLCDQ7NUS2EUR:XO · BBG00JVLCDR6NUS2EUR:XS · BBG00JVLCDW0NUS2EUR:XA · BBG00JVLCDX9NUS2EUR:E1 · BBG00JVLCDY8NUS2EUR:XT · BBG00JVLCDZ7NUS2EUR:XW · BBG00JVLCF00NUS2EUR:XU · BBG00JVLCF19NUS2EUR:XV · BBG00JVLCF28NUS2EUR:XM · BBG00JVLCF37NUS2EUR:XQ · BBG00JVLCF55NUS2EUR:XX · BBG00JVLCF64NUS2EUR:XZ · BBG00JVLCF73NUS2EUR:EU · BBG00JVLCF91NUS1GBP:XS · BBG00KVCPVL5NUS1GBP:XH · BBG00KVCPVP1NUS1GBP:XF · BBG00KVCPVR9NUS1GBP:XE · BBG00KVCPVT7NUS1GBP:XJ · BBG00KVCPVV4NUS1GBP:XL · BBG00KVCPVW3NUS1GBP:XG · BBG00KVCPVX2NUS1GBP:XO · BBG00KVCPVY1NUS1GBP:XA · BBG00KVCPW24NUS1GBP:E1 · BBG00KVCPW33NUS1GBP:XT · BBG00KVCPW42NUS1GBP:XW · BBG00KVCPW51NUS1GBP:XU · BBG00KVCPW60NUS1GBP:XV · BBG00KVCPW79NUS1GBP:XM · BBG00KVCPW88NUS1GBP:XQ · BBG00KVCPWB4NUS1GBP:XX · BBG00KVCPWC3NUS1GBP:XZ · BBG00KVCPWD2NUS1GBP:EU · BBG00KVCPWG9NUSN:PO · BBG00M0XKWR6NUSN:L3 · BBG00M0XL120NUSN:B3 · BBG00M0XL2X4NUS:TH · BBG00P2GCMB2NUS:VG · BBG00X1LTF95NUS:VP · BBG00X1Q7Q76NUSN:L1 · BBG00Y92HJN6NUS:LA · BBG018H7LY63NUS:LU · BBG018J180N4

All fundamentals about NU Skin Enterprises

Our stock analysis for NU Skin Enterprises Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NU Skin Enterprises Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

NU Skin Enterprises Revenue→

NU Skin Enterprises Net Income→

NU Skin Enterprises P/E→

NU Skin Enterprises P/S→

NU Skin Enterprises EBIT→

NU Skin Enterprises Dividend→

NU Skin Enterprises Directors Dealings→

NU Skin Enterprises Stocks→

NU Skin Enterprises Market capitalization→

NU Skin Enterprises Debt→

NU Skin Enterprises Liabilities→

NU Skin Enterprises Equity→

NU Skin Enterprises AAQS→

NU Skin Enterprises Employees→

NU Skin Enterprises ROE→

NU Skin Enterprises ROA→

NU Skin Enterprises ROCE→